Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fibronectin in pemphigus.

T Hunziker, J J Morgenthaler, H A Gerber

    Dermatologica
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Fibronectin may protect against pemphigus by reducing antibody penetration in the skin. Lower fibronectin levels correlate with active pemphigus disease, suggesting a potential therapeutic role.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Healing times and the need for hospitalization for leg ulcers of different etiologies].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2013
    Same author

    [Extracorporeal shock wave therapy as a treatment of a non-healing chronic leg ulcer].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2013
    Same author

    Post-surgical scalp wounds with exposed bone treated with a plant-derived wound therapeutic.

    Journal of wound care·2012
    Same author

    [Lupus erythematosus: in which skin changes cases should we think about it, what's clear?].

    Revue medicale suisse·2012
    Same author

    Irradiation with water-filtered infrared A plus visible light improves cutaneous scleroderma lesions in a series of cases.

    Dermatology (Basel, Switzerland)·2011
    Same author

    Cultivation of keratinocytes from the outer root sheath of human hair follicles.

    Methods in molecular medicine·2011
    Same journal

    Radiodermatitis with late ulcer (sarcoma) for 34 years.

    Dermatologica·2010
    Same journal

    Alopecia decalvans, totalis, maligna, with nail changes and tooth abnormalities.

    Dermatologica·2010
    Same journal

    Epidermolysis bullosa tarda simplex.

    Dermatologica·2010
    Same journal

    Blistering after psychological arousal.

    Dermatologica·2010
    Same journal

    Mycosis fungoides in the tumor stage.

    Dermatologica·2010
    Same journal

    Photoallergic rash after Irgafen.

    Dermatologica·2010
    See all related articles

    Area of Science:

    • Dermatology
    • Immunology
    • Biochemistry

    Background:

    • Pemphigus is an autoimmune blistering disease affecting the skin.
    • The role of fibronectin in pemphigus pathogenesis is not fully understood.

    Purpose of the Study:

    • To investigate the potential protective role of fibronectin in pemphigus.
    • To examine fibronectin levels in pemphigus patients and its correlation with disease activity.

    Main Methods:

    • Skin organ culture model to assess fibronectin's effect on acantholysis.
    • Chromatography and precipitation assays to evaluate fibronectin-antibody interaction.
    • Measurement of plasma and blister fluid fibronectin concentrations in pemphigus patients.

    Main Results:

    Related Experiment Videos

    • High fibronectin concentrations inhibited pemphigus plasma-induced acantholysis and antibody binding in vitro.
    • No direct interaction was found between fibronectin and pemphigus antibodies.
    • Pemphigus patients with active disease showed low to subnormal plasma fibronectin levels.
    • Fibronectin levels tended to decrease with disease remission during treatment.

    Conclusions:

    • Fibronectin may exert a protective effect in pemphigus, potentially by limiting antibody access to the dermal-epidermal junction.
    • Reduced fibronectin levels in active pemphigus suggest its involvement in disease progression.